Table 1.
Variants | Patients |
---|---|
Age (years) | |
<55 | 40 (60.6%) |
≥55 | 26 (39.4%) |
Sex | |
Male | 30 (45.5%) |
Female | 36 (55.5%) |
Aggressiveness | |
Mild | 34 (51.5%) |
Severe | 32 (48.5%) |
Flu Vaccine | |
No | 44 (66.7%) |
Yes | 21 (31.8%) |
Missing | 1 (1.5%) |
Long COVID | |
No | 62 (93.9%) |
Yes | 1 (1.5%) |
Missing | 3 (4.5%) |
Pneumonia | |
No | 33 (50%) |
Yes | 31 (47%) |
Missing | 2 (3%) |
Systemic inflammatory response | |
No | 45 (68.2%) |
Yes | 18 (27.3%) |
Missing | 3(4.5%) |
Long COVID, individuals with confirmed SARS CoV-2 infection with symptoms that last for at least 2 months and cannot be explained by an alternative diagnosis.
Mo_Classical: Classical Monocytes.
Mo_Transitional: Transitional Monocytes.
Mo_Nonclassical Non classical Monocytes.